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Introduction
3
Pre-eclampsia is a hypertensive disorder of pregnancy that occurs in ~3% of all pregnancies.
51
This disease, which manifests as high blood pressure and proteinuria, is probably mediated 52 by endothelial damage and may affect multiple systems of the body and contribute to adverse 53 pregnancy outcomes including maternal death, preterm birth, intrauterine growth restriction 54 (IUGR) and fetal death [1] . Together with other hypertensive disorders of pregnancy, pre-55 eclampsia is responsible for at least 60,000 maternal deaths each year [2] and increases 56 perinatal mortality 5-fold [3] . Placental and maternal systemic oxidative stress are 57 components of the syndrome [4, 5] and contribute to a generalised maternal systemic 58 inflammatory activation [6] . Placental ischemia-reperfusion injury has been implicated in 59 excessive production of reactive oxygen species (ROS), which could cause release of 60 placental factors that mediate the inflammatory responses [7] . We have recently shown that 61 placental antioxidant glutathione peroxidise (GPx) activity and expression are reduced in pre-62 eclampsia [8] .
64
The renin-angiotensin system (RAS) is known to be an important regulator of blood pressure, 65 sodium and fluid homeostasis. In non-pregnant models, enhanced RAS neonates from both pregnancy groups survived.
185
All components of the RAS that were measured in this study were found to be expressed in There is some controversy surrounding the regulation of placental AT1R in pre-eclampsia.
247
The increase in placental AT1R expression in pre-eclampsia we observed is in agreement
248
with previous studies in placental [44] 
